NCT06309589Completed
The Effectiveness of Combining Ursodeoxycholic Acid With Vitamin D in Treating Patients With Primary Biliary Cholangitis
Department of Infectious Diseases, People's Hospital of Xinjiang Uygur Autonomous Region
Source: ClinicalTrials.gov · Last updated 13 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial is to compare in the effectiveness of combining ursodeoxycholic acid and vitamin D in treating patients with primary biliary cholangitis.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 1 Mar 2024
- Start date
- 1 May 2021
- Primary completion date
- 30 Sept 2023
- Lead sponsor
- Yilihamu·Abilitifu
- Diseases
- Primary biliary cholangitis
- NCT number
- NCT06309589
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 1 May 2021 to the primary completion date, 30 Sept 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who randomly interrupted or adjusted their medication during the treatment period were excluded.
Other illness
- The study excluded patients with autoimmune hepatitis or primary sclerosing cholangitis.
- Patients with other acute and chronic liver diseases were also excluded.
- Patients with serious cardiopulmonary diseases were excluded as well.
Other
- Pregnant or lactating women were not included in the study.
- Patients who lacked follow-up were also excluded.
Who the study is looking for
- The patient must meet the diagnostic criteria for PBC ;
- The patient must have been diagnosed at the age of 18 or older;
- The patient must have completed at least 2 years of treatment and have complete and accessible clinical data;
- The patient must have strictly followed the doctor's prescription during the treatment period and not have interrupted the treatment arbitrarily.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| People's Hospital of Xinjiang Uygur Autonomous Region Coordinator of this site? Confirm its status | Ürümqi | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.